BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12408909)

  • 1. Spectrofluorometric determination of labetolol in pharmaceutical preparations and spiked human urine through the formation of coumarin derivative.
    Belal F; Al-Shaboury S; Al-Tamrah AS
    J Pharm Biomed Anal; 2002 Nov; 30(4):1191-6. PubMed ID: 12408909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micellar enhanced spectrofluorometric determination of labetalol through complexation with aluminium(III): application to dosage forms and biological fluids.
    El-Enany N
    J AOAC Int; 2007; 90(4):948-56. PubMed ID: 17760332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectrophotometric determination of labetalol in pharmaceutical preparations and spiked human urine.
    Belal F; Al-Shaboury S; Al-Tamra AS
    Farmaco; 2003 Apr; 58(4):293-9. PubMed ID: 12727538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectrofluorometric determination of nimodipine in dosage forms and human urine.
    Belal F; Al-Majed AA; Julkhuf S; Khalil NY
    Pharmazie; 2003 Dec; 58(12):874-6. PubMed ID: 14703964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Derivatization of labetalol hydrochloride for its spectrofluorimetric and spectrophotometric determination inhuman plasma: Application to stability study.
    Omar MA; Derayea SM; Abdel-Lateef MA; El Hamd MA
    Spectrochim Acta A Mol Biomol Spectrosc; 2018 Feb; 190():457-463. PubMed ID: 28961530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrofluorometric determination of some beta-blockers in tablets and human plasma using 9,10-dimethoxyanthracene-2-sodium sulfonate.
    Abdine H; Sultan MA; Hefnawy MM; Belal F
    Pharmazie; 2005 Apr; 60(4):265-8. PubMed ID: 15881605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrofluorometric determination of methocarbamol in pharmaceutical preparations and human plasma.
    Walash M; Belal F; Eid M; EL Abass SA
    J Fluoresc; 2011 Mar; 21(2):555-61. PubMed ID: 20936330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrofluorimetric determination of oseltamivir phosphate through derivatization with o-phthalaldehyde. Application to pharmaceutical preparations with a preliminary study on spiked plasma samples.
    Walash MI; Belal F; El-Enany N; El-Maghrabey MH
    Luminescence; 2012; 27(6):511-8. PubMed ID: 22362604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrofluorimetric determination of labetalol hydrochloride in pharmaceutical preparations and urine samples.
    Rahman N; Haque SM
    Int J Biomed Sci; 2008 Jun; 4(2):140-6. PubMed ID: 23675081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrofluorimetric determination of coumarin in commercial tablets.
    Marcolan M; Martins PA; Pedrosa VA; Rodrigues MR; de Oliveira HP; Codognoto L
    J Fluoresc; 2011 Mar; 21(2):733-8. PubMed ID: 21046436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of mixed anhydrides for the determination of terfenadine in dosage forms and spiked human plasma.
    Al-Majed AA; Al-Zehouri J; Belal F
    J Pharm Biomed Anal; 2000 Aug; 23(2-3):281-9. PubMed ID: 10933521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrofluorimetric determination of famotidine in pharmaceutical preparations and biological fluids. Application to stability studies.
    Walash MI; el-Brashy A; el-Enany N; Kamel ME
    J Fluoresc; 2009 Mar; 19(2):333-44. PubMed ID: 18956234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous determination of labetalol and furosemide by first-derivative synchronous spectrofluorimetry.
    El-Wasseef DR; El-Sherbiny DT; Abu-El-Enein MA; El-Ashry SM
    J Fluoresc; 2009 Sep; 19(5):817-28. PubMed ID: 19408106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validated spectrofluorimetric method for the determination of lamotrigine in tablets and human plasma through derivatization with o-phthalaldehyde.
    El-Enany NM; El-Sherbiny DT; Abdelal AA; Belal FF
    J Fluoresc; 2010 Mar; 20(2):463-72. PubMed ID: 19943095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective spectrofluorimetric determination of phenolic beta-lactam antibiotics through the formation of their coumarin derivatives.
    El Walily AF; Gazy AA; Belal SF; Khamis EF
    J Pharm Biomed Anal; 1999 Aug; 20(4):643-53. PubMed ID: 10704133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrofluorometric determination of fluvoxamine in dosage forms, spiked plasma, and real human plasma by derivatization with fluorescamine.
    El-Enany N
    J AOAC Int; 2007; 90(2):376-83. PubMed ID: 17474508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Validation of highly Sensitive Stability Indicating Spectrofluorimetric Method for Determination of Amlodipine in Pharmaceutical Preparations and Human Plasma.
    Mohamed AI; Omar MA; Hammad MA; Mohamed AA
    J Fluoresc; 2016 Nov; 26(6):2141-2149. PubMed ID: 27566613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrofluorimetric determination of paroxetine HCl in pharmaceuticals via derivatization with 4-chloro-7- nitrobenzo-2-oxa-1,3-diazole (NBD-Cl).
    Walsh M; Belal F; El-Enany N; Elmansi H
    J Fluoresc; 2011 Jan; 21(1):105-12. PubMed ID: 20593227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitive spectrofluorimetric determination of tizanidine in pharmaceutical preparations, human plasma and urine through derivatization with dansyl chloride.
    Ulu ST
    Luminescence; 2012; 27(5):426-30. PubMed ID: 23044773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simple and sensitive spectrofluorimetric method for the determination of pregabalin in capsules through derivatization with fluorescamine.
    Walash MI; Belal F; El-Enany N; El-Maghrabey MH
    Luminescence; 2011; 26(5):342-8. PubMed ID: 20737649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.